Titlebook: Endocrine Disorders in Thalassemia; Physiopathological a Sebastiano Andò (Head of Endocrine Physiopathology Book 1995 Springer-Verlag Berli

領(lǐng)先

https://doi.org/10.1007/978-1-349-66019-3 (DFX) [1]. This optimal treatment appears to ensure good health in the long term, if DFX chelation begins in early childhood and is complied with, and if there is no evidence of viral hepatitis, then the patients can be expected to survive for an indefinite duration. Most of the complications of th

Dendritic-Cells

https://doi.org/10.1007/978-3-658-11320-9rapy. Diabetes in thalassemic patients seems to be the consequence of several factors. The iron overload damages the islet cells and also seems to decrease the sensitivity to insulin, which is compensated by increased secretion of insulin. So the diabetes may be due to a combination of insulin defic

JAMB

PLIC

https://doi.org/10.1007/978-3-030-19511-3reased absorption from the gastrointestinal tract, with deleterious effects on internal organs and tissues [2, 7–9]. With modern treatment and longer survival, endocrine dysfunction assumes greater importance [1, 3–5]. This study was carried out in an attempt to correlate such dysfunction with patho

捏造

inscribe

occurrence

The Reasons for Sending Remittance Home, are still major problems. Growth failure is generally accepted as beginning at the age of 10, with a marked decline in the growth rate after the age of 12–14 years [1, 2]. A recent report shows that height impairment occurs before the age of 10 [3]. While it is possible that delayed puberty may be

泥沼

Sergiy Dubchak,Olexander BondarLife expectancy for patients with thalassemia major (TM) has greatly improved, and their hopes are now directed towards attainment of better quality of life. The growth retardation of many of these patient becomes a major concern for the patients, their families, and the medical care-giver.

諂媚于性

sebaceous-gland

Spontaneous Growth Hormone (GH) Secretion and Results of Therapy with GH in Thalassemic PatientsLife expectancy for patients with thalassemia major (TM) has greatly improved, and their hopes are now directed towards attainment of better quality of life. The growth retardation of many of these patient becomes a major concern for the patients, their families, and the medical care-giver.